1. Кисина В.И., Сидурский С.В., Фаттяхетдинов Р.Ш., Ширшова Е.В.
Сравнительная эффективность лечения негонококкового уретрита у
мужчин с помощью генетического и оригинального азитромицина. Клин.
дерматол. и венерол. 2008; 5: 64–8.
2. Povisen K, Douglas JM, Ragsdaie, Foster M. Relationship of U. urealyticum
biovar 2 to nongonococcal urethritis. Eur J Clin Microbiol Inf Dis 2002; 21 (2):
97–101.
3. Horner P, Thomas B, Gilroy CB et al. Role of M. genitalium and U. urealyticum
in acute and chronic nongonococcal uretritis. Clin Jnf Dis 2001; 32 (7):
995–1003.
4. Heying W, Meiqin S, Weihong L et al. Detection of new mycoplasma species
and other pathogenic mycoplasmas in patients with nongonococcal urethritis. Int
J STD AIDS 2001; 12 (Suppl. 2): 107.
5. Robertson BD, Meyer TF. Genetic variation in pathogenic bacteria. Trends
Genet 1992; 8: 422–7.
6. Naessens A. Les infections a Ureaplasma urealyticum. Microbiol Acta Urol
Belg 1993; 61 (1, 2): 153–6.
7. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas.
Microbiol Molecular Biol Rev 1998; 62: 1094–156.
8. Yoshida T, Deguchi T, Meda S et al. Quantitative detection of Ureaplasma
parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in urine specimens
from men with and without urethritis by Real-Time polymerase chain reaction.
Sex Transm Dis 2007; 34 (6): 416–9.
9. Ross J, Jensen J. Mycoplasma genitalium as a sexually transmitted infection:
implications for sereening, testing and treatment. Sex Trans Infections 2006; 82:
269–71.
10. Taylor-Robinson D, Horner PJ. The role of Mycoplasma genitalium in nongonococcal
urethritis. Sex Transm Infect 2001; 77: 229–31.
11. Zhang S, Wear DJ, Lo S-C. Mycoplasmal infections alter gene expression in
cultured human prostatic and cervical epithelial cells. FEMS Immunol Med Microbiol
2000; 27: 43–50.
12. Jensen JS, Ørsum R, Dohn B et al. Mycoplasma genitalium: a cause of male
urethritis? Genitourim Med 1993; 69: 265–9.
13. Horner PJ, Gilroy CB, Thomas BJ et al. Association of Mycoplasma genitalium
with acute non-gonococcal urethritis. Lancet 1993; 342: 582–5.
14. Jensen JS. Mycoplasma genitalium infections. Diagnosis, clinical aspects,
and pathogenesis. Kopenhagen 2005.
15. Manhart LE, Critchlow CW, Holmes KK. Mucopurulent cervicitis and
Mycoplasma genitalium. J Inf Dis 2003; 187: 650–7.
16. Cohen CR, Manhart LE, Bukusi AS. Association between Mycoplasma
genitalium and acute endometritis. Lancet 2002; 359: 765–6.
17. Simms I, Eastick K, Mallinson H. Associations between Mycoplasma genitalium,
Chlamydia trachomatis, and pelvic inflammatory disease. Sex Transm
Infect 2003; 79: 154–6.
18. Clausen HF, Fedder J, Drasbek M. Serological investigation of Mycoplasma
genitalium in infertile women. Hum Reprod 2001; 16: 1866–74.
19. Lu GC, Schwebke JR, Duffy LB. Midtrimester vaginal Mycoplasma genitalium
in women with subsequent spontaneous preterm birth. Am J Obstet Gynecol
2001; 185: 163–5.
20. Oakeshott P, Hay P, Taylor-Robinson D et al. Prevalence of Mycoplasma
genitalium in early pregnancy and the relationship between its presence and pregnancy
outcome. Br J Obstet Gynaecol 2004.
21. Keane EF, Thomas BJ, Gilroy CB et al. The association of Mycoplasma
hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial
vaginosis: observations on heterosexual women and their male partners. Int J STD
AIDS 2000; 11: 356–60.
22. Manhart LE, Critchlow CW, Holmes KK. Mucopurulent cervicitis and
Mycoplasma genitalium. J Inf Dis 2003; 187: 650–7.
23. Taylor-Robinson D, Thomas BJ, Dixey J et al. Evidence that Clamydia trachomatis
causes seronegative arthritis im women. Ann Rheum Dis 1988; 47:
295–9.
24. Taylor-Robinson D, Gilroy CB, Horowitz S, Horowitz J. Mycoplasma genitalium
in the joints of two patients with arthritis. Eur J Clin Microbiol Infect Dis
1994; 13: 1066–9.
25. Tully JG, Rose DL, Baseman JB et al. Mycoplasma pneumoniae and Mycoplasma
genitalium mixture in synovial fluid isolate. J Clin Microbiol 1995; 33:
1851–5.
26. Bjornelius E, Lidbrink P, Jensen JS. Conjuctivitis associated with Mycoplasma
genitalium infection. Clin Infect Dis 2004; 2: 134–6.
27. Савичева А.М. Этиологическая диагностика и терапия репродук-
тивно значимых инфекций. Трудный пациент. 2007; 5 (1): 21–8.
28. Yoshida T, Ishiko H, Yasuda M et al. Polymerase chain reaction-based subtyping
of Ureaplasma parvum and Ureaplasma urealyticum in first-pass urine
samples from men with or without urethritis. Sex Transm Dis 2005; 32 (7): 454–7.
29. Дмитриев Г.А. Качество лабораторной диагностики инфекций,
передаваемых половым путем. Cons. Med. 2005; 7 (3): 197–200.
30. Козлова В.И., Пухнер А.Ф. Вирусные, хламидийные и микоплазменные
заболевания гениталий: Руководство для врачей. СПб., 2000.
31. Кобахидзе М.Ш., Автушенко С.С., Гончарова С.А. Инфекция
Mycoplasma hominis при некоторых воспалительных процессах мочеполо-
вого тракта человека. Вестн. АМН СССР. 1976; 5: 76–80.
32. Battle TJ, Golden MR, Suchland KL et al. Evaluation of laboratory testing
methods for Chlamydia trachomatis infection in the era of nucleic acid amplification.
J Clin Microbiol 2001; 39: 2924–7.
33. Blaylock MW, Musatovova O, Baseman JG, Baseman JB. Determination
of Infectious Load of Mycoplasma genitalium in Clinical Samples of Human
Vaginal Cells. J Clin Microbiol 2004; 42 (2): 746–52.
34. Evans RT et al. The incidence of tetracycline-resistant strains of Ureaplasma
urealyticum. J Antimicrob Chemother 1978; 4: 57–63.
35. Taylor-Robinson D. The role of Ureaplasma urealyticum. Int J STD AIDS
1998; 9 (2): 123–4.
36. Kundsin RB, Poulin SA. Ureaplasma urealyticum: subcultures invalid for
antibiotic susceptibility tests. Diagn Microbiol Infect Dis 1985; 3 (4): 329–36.
37. Страчунский Л.С., Козлов С.Н. Современная антимикробная тера-
пия: Руководство для врачей. М.: Боргес, 2002.
38. Falk L, Fredlund H, Jensen JS. Tetracycline treatment does not eradicate
Mycoplasma genitalium. Sex Transm Infect 2003; 79: 318–9.
39. Falk L, Jensen JS. Mycoplasma genitalium prevalence, symptoms, signs and
treatment efficacy among attendees at a Swedish STD outpatient clinic. Int J STD
AIDS 2001; 12: 107.
40. Проект Национального стандарта «Уретрит и(или) цервицит,
ассоциированный с генитальными микоплазмами». Врач. 2009; 1: 67–83.
41. Веселов А.В., Козлов Р.С. Азитромицин: современные аспекты клини-
ческого применения. Клин. микробиол. и антимикроб. химиотер. 2007; 8: 1.
42. Lauharanta J, Saarinen K, Mustonen M-T et al. Single oral azithromycin
versus seven day doxycycline in the treatment of non-gonococcal urethritis in
males. J Antimicrob Chemother 1993; 31: 177–83.
43. Omura S. Macrolid Antibiotics. 2ed. Acadimic Press, 2002.
44. Ridgway GL. Azithromycin in the management of Chlamydia trachomatis
infections. Int J STD AIDS 1996; 7 (1): 5–8.
45. Stout JE, Sens K, Mietzner S. Comparative activity of quinolones, macrolides
and ketolides against Legionella species using in vitro broth dilution and intracellular
susceptibility testing. Int J Antimicrob Agents 2005; 25: 302–7.
46. Комаров Р.В., Деревянко И.И., Яковлев С.В. и др. Фармакокинетика
азитромицина при урогенитальных инфекциях. Инф. и антимикроб. тер.
2001; 3: 6.
47. Кисина В.И., Ширшова Е.В., Забиров К.И., Мартазинова С.К. Совре-
менные подходы к диагностике и лечению негонококковых уретритов. Cons.
Med. 2005; 7: 1.
48. Bradshan CS, Tabsiri SM, Read TR. Mycoplasma genitalium, herpes simplex
viruses and adenoviruses in non-gonococcal urethritis. 16th Biennial
Meeting of the International Society for Sexually Trans Dis Research. Amsterdam,
2005.

В.И.Кисина
Первый МГМУ им. И.М.Сеченова